Liquid Biopsies Identify Cancer Patients Who are at Higher Risk of Additional Blood Cancers
Researchers found that liquid biopsies can detect a disorder of blood cells that places patients at higher risk of developing blood cancers.
Researchers found that liquid biopsies can detect a disorder of blood cells that places patients at higher risk of developing blood cancers.
Thyroid cancer is the fastest growing cancer in the US, and is the 5th most common cancer in women often present years before being detected.
Researchers have developed a biosensor that could help physicians precisely diagnose brain cancer from a minute blood sample.
Invitae released a study recommending genetic testing for those with breast cancer, and showing how testing improves patient outcomes.
Read MoreIt may soon be possible to identify Group 4 medulloblastomas, a common malignant brain tumor in children, from aggressive Group 3 tumors.
Read MoreMobiDev has approached the WSI processing system design through clustering, a constrained attention multiple instance learning approach.
Read MoreExai Bio presented data from a new study in a poster entitled “Serum-based colorectal cancer detection using orphan noncoding RNAs.”
Read MoreUnilabs and Proscia have announced that the diagnostic group has chosen Proscia’s DermAI skin pathology solution.
Read MorePatients at St. Elizabeth Healthcare can be screened for 50 different types of cancer, thanks to a new cancer-detecting blood test.
Read MoreNew tech can capture stray ovarian cancer cells from a blood test and predict cancer in those who have a lesion or cyst in the pelvic region.
Read MoreImplementing lung cancer screening at four diverse healthcare systems resulted in a 6.6% decrease in Stage IV disease.
Read MoreLeica Biosystems and Indica Labs announced a partnership where they will focus on delivering compatible digital pathology workflow solutions.
Read MoreCAR-T cell therapy has revolutionized the treatment of several cancers, using modified T cells to target types of leukemia & lymphoma.
Read MoreExai Bio combines novel oncRNA technology with AI to develop next-generation liquid biopsy tests that will aid in the detection of cancer.
Read MoreCedars-Sinai Cancer investigators have created a blood test that uses a technology to detect the most common form of liver cancer.
Read MoreA new research paper “Using quantitative immunohistochemistry in patients at high risk for hepatocellular cancer” was published.
Read MoreA new collaborative project has successfully demonstrated a superior ability to detect circulating tumor DNA (ctDNA) from saliva.
Read MoreMen at the highest risk for prostate cancer could be fast-tracked for investigation if their genetic risk was considered in general practice.
Read More